NUVB insider buying and SEC filings, explained
Nuvation Bio Inc. · CIK 1811063
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$118K
Insiders who bought
1
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$3.5M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Aug 19, 2026 | Planned (10b5-1) | Gary Hattersley (Chief Scientific Officer) sold 100,000 shares at about $7.09 ($709K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Aug 21, 2026 |
| Jun 23, 2026 | Planned (10b5-1) | Philippe Sauvage (CFO) sold 47,668 shares at about $6.01 ($286K), marked as a 10b5-1 plan trade. Holdings down 79% to 12,673 shares. | SEC filing Filed Jun 24, 2026 |
| Jun 23, 2026 | Planned (10b5-1) | Stacy Markel (Chief People Officer) sold 125,000 shares at about $6.03 ($754K), marked as a 10b5-1 plan trade. Holdings down 79% to 32,591 shares. | SEC filing Filed Jun 24, 2026 |
| Jun 23, 2026 | Planned (10b5-1) | Kerry Wentworth (Chief Regulatory Officer) sold 63,000 shares at about $6.02 ($379K), marked as a 10b5-1 plan trade. Holdings down 54% to 53,000 shares. | SEC filing Filed Jun 24, 2026 |
| Jun 9, 2026 | Purchase (code P) | Robert Mashal (Director) bought 25,000 shares indirectly (by trust) at $4.73 ($118K), reported as a purchase (code P). Holdings by trust up 13% to 225,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 11, 2026 |
| Apr 17, 2026 | Planned (10b5-1) | Dongfang Liu (Chief Medical Officer) sold 50,000 shares at about $5.02 ($251K), marked as a 10b5-1 plan trade. Holdings down 74% to 18,000 shares. | SEC filing Filed Apr 21, 2026 |
| Apr 17, 2026 | Planned (10b5-1) | Kerry Wentworth (Chief Regulatory Officer) sold 36,750 shares at about $5.01 ($184K), marked as a 10b5-1 plan trade. Holdings down 41% to 53,000 shares. | SEC filing Filed Apr 21, 2026 |
| Apr 6, 2026 | Planned (10b5-1) | Kerry Wentworth (Chief Regulatory Officer) sold 200,000 shares at about $4.52 ($904K), marked as a 10b5-1 plan trade. Holdings down 79% to 53,000 shares. | SEC filing Filed Apr 8, 2026 |
36 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow NUVB in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.